Linda joined the BioPharma industry in 1983 and has spent the last 30+ years in regulatory strategy, policy, and intelligence roles at Pfizer (Seagen), Sanofi, Bayer, and GSK. She has been an Adjunct Professor in the Temple University RAQA graduate program since 1998.

She attained regulatory affairs certification for the US, Canada, and Europe, and was an inductee to the 2011 Class of RAPS Fellows. Linda was honored with the Drug Information Association's 2012 Excellence in Volunteer Leadership, the 2019 Americas Inspire Awards, and the 2022 Global Inspire Award - Community Engagement as well as the RAPS 2020 Founder’s Award.

She is a past two-term member of the RAPS Board of Directors, current chair of the RAPS Industry Board, and immediate past chair of the NJ/NY RAPS Chapter. Linda is past Chair of the DIA Regulatory Affairs Community and founder of the DIA Regulatory Intelligence Working Group. She sat on the planning committee for 2013-2017 DIA Annual Conference, the 2011-2017 RAPS Annual Convergence and was Program Chair for the 2018 & 2019 RAPS Annual Convergence. She is co-chair of the RAPS 2024-2026 Regulatory Intelligence Conference.